In all CRC samples, PLXNA3 expression was significantly higher in malignant regions compared to non-malignant areas (p < 0.05; Figure 7B and Supplementary Figure 3B), underscoring its spatial enrichment in tumor tissue. This evidence concerns the gene PLXNA3 and neoplasm.